194 related articles for article (PubMed ID: 37626865)
21. Aberrant Expression of
Skorka K; Wlasiuk P; Karczmarczyk A; Giannopoulos K
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33669782
[TBL] [Abstract][Full Text] [Related]
22. Could Immune Checkpoint Disorders and EBV Reactivation Be Connected in the Development of Hematological Malignancies in Immunodeficient Patients?
Mertowska P; Mertowski S; Smolak K; Kita G; Guz K; Kita A; Pasiarski M; Smok-Kalwat J; Góźdź S; Grywalska E
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835480
[TBL] [Abstract][Full Text] [Related]
23. IFNs activate toll-like receptor gene expression in viral infections.
Miettinen M; Sareneva T; Julkunen I; Matikainen S
Genes Immun; 2001 Oct; 2(6):349-55. PubMed ID: 11607792
[TBL] [Abstract][Full Text] [Related]
24. Toll-like receptors as adjuvant receptors.
Kaisho T; Akira S
Biochim Biophys Acta; 2002 Feb; 1589(1):1-13. PubMed ID: 11909637
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the TLR negative regulatory network in CVID patients.
Sanaei R; Rezaei N; Aghamohammadi A; Delbandi AA; Teimourian S; Yazdani R; Tavasolian P; Kiaee F; Tajik N
Genes Immun; 2019 Mar; 20(3):198-206. PubMed ID: 29618830
[TBL] [Abstract][Full Text] [Related]
26. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis.
Mishra BB; Mishra PK; Teale JM
J Neuroimmunol; 2006 Dec; 181(1-2):46-56. PubMed ID: 17011049
[TBL] [Abstract][Full Text] [Related]
27. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.
Nagase H; Okugawa S; Ota Y; Yamaguchi M; Tomizawa H; Matsushima K; Ohta K; Yamamoto K; Hirai K
J Immunol; 2003 Oct; 171(8):3977-82. PubMed ID: 14530316
[TBL] [Abstract][Full Text] [Related]
28. The impact of single and pairwise Toll-like receptor activation on neuroinflammation and neurodegeneration.
Rosenberger K; Derkow K; Dembny P; Krüger C; Schott E; Lehnardt S
J Neuroinflammation; 2014 Sep; 11():166. PubMed ID: 25239168
[TBL] [Abstract][Full Text] [Related]
29. The role of toll-like receptors in B-cell development and immunopathogenesis of common variable immunodeficiency.
Sharifi L; Mirshafiey A; Rezaei N; Azizi G; Magaji Hamid K; Amirzargar AA; Asgardoon MH; Aghamohammadi A
Expert Rev Clin Immunol; 2016; 12(2):195-207. PubMed ID: 26654573
[TBL] [Abstract][Full Text] [Related]
30. TLRs govern neutrophil activity in aspergillosis.
Bellocchio S; Moretti S; Perruccio K; Fallarino F; Bozza S; Montagnoli C; Mosci P; Lipford GB; Pitzurra L; Romani L
J Immunol; 2004 Dec; 173(12):7406-15. PubMed ID: 15585866
[TBL] [Abstract][Full Text] [Related]
31. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
32. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K
Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589
[TBL] [Abstract][Full Text] [Related]
33. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation.
Månsson A; Adner M; Höckerfelt U; Cardell LO
Immunology; 2006 Aug; 118(4):539-48. PubMed ID: 16780564
[TBL] [Abstract][Full Text] [Related]
34. Regulation of dendritic cell function through Toll-like receptors.
Kaisho T; Akira S
Curr Mol Med; 2003 Jun; 3(4):373-85. PubMed ID: 12776992
[TBL] [Abstract][Full Text] [Related]
35. Messenger RNA expression of toll-like receptors (TLR2, TLR4, and TLR9) in HIV-1 infected patients with and without tuberculosis co-infection.
Kaushik G; Vashishtha R
Int J Mycobacteriol; 2022; 11(3):293-298. PubMed ID: 36260448
[TBL] [Abstract][Full Text] [Related]
36. Influence of genetic variability in toll-like receptors (TLR 2, TLR 4, and TLR 9) on human immunodeficiency virus-1 disease progression.
Kaushik G; Vashishtha R
Int J Mycobacteriol; 2023; 12(1):10-16. PubMed ID: 36926756
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells.
Schaefer TM; Desouza K; Fahey JV; Beagley KW; Wira CR
Immunology; 2004 Jul; 112(3):428-36. PubMed ID: 15196211
[TBL] [Abstract][Full Text] [Related]
38. Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women.
Hasimu A; Ge L; Li QZ; Zhang RP; Guo X
Chin J Cancer; 2011 May; 30(5):344-50. PubMed ID: 21527067
[TBL] [Abstract][Full Text] [Related]
39. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
Andersen JM; Al-Khairy D; Ingalls RR
Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the Effectiveness of the 6 Warning Signs of the European Society for Immunodeficiencies for Primary Immunodeficiencies in Older Adults.
Yildiz E; Çölkesen F; Evcen R; Sadi Aykan F; Kılınç M; Arslan S
Int Arch Allergy Immunol; 2024; 185(4):402-410. PubMed ID: 38219730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
